menu-hamburger-svgrepo-com

GINA 2022 update

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

When selecting initial controller treatment in adults and adolescents with the diagnosis of asthma, the Global Initiative for Asthma (GINA), recommends the following.  

Steps 1 to 2: As-needed low-dose ICS formoterol: additional evidence has been added including a systematic review showing significant reduction in emergency visits/ hospitalisations with as-needed ICS-formoterol compared with daily ICS plus as-needed SABA; greater reduction in severe exacerbations in adults and adolescents previously taking SABA alone with as-needed ICS-formoterol compared with daily ICS plus as-needed SABA; similar findings in adolescence as adults, and additional safety data.  

STARTING TREATMENT  

Track one is preferred if the patient is likely to be poorly adherent with daily controller. ICS-containing therapy is recommended even if symptoms are in frequent, as it reduces the risk of severe exacerbations and need for OCS. 

Selecting initial controller treatment in adults and adolescents with asthma 

asthma graph

Abbreviations: ICS: inhaled corticosteroid; SABA: short-acting β2-agonist; LAMA: Long-acting muscarinic antagonists; MART: maintenance and reliever therapy with ICS-formoterol; OCS: oral corticosteroids; SABA: short-acting beta2-agonist. 

REFERENCES: Global initiative for asthma. Global strategy for asthma management and prevention, 2022.  Available from: www.Ginasthma.org 

Suggested Articles

Suggested Clinical & CPD content

CPD: 1pt

Related articles

Welcome to Medical Academic​

Get the most out of Medical Academic by telling us your occupation. This helps us create more great content for you and the community.

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Please check your email for an activation mail. Click the activation link to activate your account

Stay up to date

Search for anything across CPD, webinars and journals
idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! You have successfully booked your seat.

All webinar details will be emailed to your email address.

Did you know, you can book future webinars with a single click if you register an account with Medical Academic.

Congratulations! Your account was successfully created.

Your webinar seat has been booked and all webinar details will be emailed to your registered email address

Why not register for Medical Academic while booking your seat for this webinar?

Future Medical Academic webinars can be booked with a single click, all with a Medical Academic account… and it’s FREE.

Book webinar & create your account

* (Required)

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Thank you for registering. You can now log in to your account.

Create your account

* (Required)

Login with One Time Pin (OTP)

Enter your registered email address to receive an OTP

A verification code will be sent to your email address. Please ensure that admin@medicalacademic.co.za is on your safe sender list.

We've sent your OTP